Positive News SentimentPositive NewsNASDAQ:TNDM Tandem Diabetes Care (TNDM) Stock Price, News & Analysis $17.11 0.00 (0.00%) Closing price 09/11/2026 04:00 PM EasternExtended Trading$17.17 +0.06 (+0.34%) As of 09/11/2026 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Tandem Diabetes Care Stock (NASDAQ:TNDM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Tandem Diabetes Care alerts:Sign Up Key Stats Today's Range$17.07▼$18.6750-Day Range$15.16▼$23.7352-Week Range$11.46▼$29.65Volume1.79 million shsAverage Volume1.39 million shsMarket Capitalization$1.19 billionP/E RatioN/ADividend YieldN/APrice Target$29.34Consensus RatingHold Company Overview Tandem Diabetes Care, Inc. is a medical technology company that develops and commercializes insulin-delivery systems for people with diabetes. Headquartered in San Diego, California, the company focuses on combining wearable insulin pumps, continuous glucose monitoring connectivity and automated insulin-delivery software to help users manage their blood glucose levels. Its product portfolio includes the t:slim X2 insulin pump, a touchscreen pump designed for integration with compatible continuous glucose monitors, and the smaller, wearable t:slim Mobi pump. Tandem’s Control-IQ advanced hybrid closed-loop technology is designed to automate insulin delivery adjustments using glucose data, while the company also provides mobile applications, data-management tools, infusion sets and related supplies. Tandem was founded in 2006 and began commercializing its first insulin pump in the United States in 2012. The company serves customers in the United States and selected international markets through direct operations and distribution partners. Its products are intended for people with insulin-dependent diabetes and are prescribed and used under the guidance of healthcare professionals.AI Generated. May Contain Errors. Read More Tandem Diabetes Care Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks57th Percentile Overall ScoreTNDM MarketRank™: Tandem Diabetes Care scored higher than 57% of companies evaluated by MarketBeat, and ranked 441st out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingHold Consensus RatingTandem Diabetes Care has received a consensus rating of Hold. The company's average rating score is 2.48, and is based on 1 strong buy rating, 10 buy ratings, 11 hold ratings, and 1 sell rating.Upside PotentialTandem Diabetes Care has a consensus price target of $29.34, representing about 71.5% upside from its current price of $17.11.Amount of Analyst CoverageTandem Diabetes Care has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Tandem Diabetes Care's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tandem Diabetes Care are expected to grow in the coming year, from ($0.65) to $0.10 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tandem Diabetes Care is -18.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tandem Diabetes Care is -18.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTandem Diabetes Care has a P/B Ratio of 7.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Tandem Diabetes Care's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted17.26% of the float of Tandem Diabetes Care has been sold short.Short Interest Ratio / Days to CoverTandem Diabetes Care has a short interest ratio ("days to cover") of 8.17.Change versus previous monthShort interest in Tandem Diabetes Care has recently increased by 11.03%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTandem Diabetes Care does not currently pay a dividend.Dividend GrowthTandem Diabetes Care does not have a long track record of dividend growth. News and Social Media4.1 / 5News Sentiment1.56 News SentimentTandem Diabetes Care has a news sentiment score of 1.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Tandem Diabetes Care this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for TNDM on MarketBeat in the last 30 days. This is a decrease of -90% compared to the previous 30 days.MarketBeat Follows6 people have added Tandem Diabetes Care to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Tandem Diabetes Care insiders have not sold or bought any company stock.Percentage Held by Insiders2.10% of the stock of Tandem Diabetes Care is held by insiders.Percentage Held by InstitutionsTandem Diabetes Care has minimal institutional ownership at this time.Read more about Tandem Diabetes Care's insider trading history. Receive TNDM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TNDM Stock News HeadlinesIs Tandem Diabetes Care Inc (TNDM) a Bargain After 4.2% Drop? GF Value Says UndervaluedSeptember 10, 2026 | gurufocus.comTandem Diabetes Care (NASDAQ:TNDM) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?September 3, 2026 | americanbankingnews.comyour job is on the listThe CEO of one of the largest AI labs on earth said it plainly: AI could wipe out half of all entry-level white-collar jobs. Another industry leader put a number on the wages shifting hands - three to twelve trillion dollars. That money does not disappear, it moves to whoever owns the machine doing the work. Dylan Jovine found the company quietly renting that machine to corporate America. | Behind the Markets (Ad)Innovative Insulin Pumps Drive Optimism for Tandem, Beta BionicsAugust 21, 2026 | benzinga.comTandem Diabetes Care (TNDM) Receives a Buy from Lake StreetAugust 16, 2026 | theglobeandmail.comOppenheimer Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM)August 14, 2026 | theglobeandmail.comTandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target MaintainedAugust 12, 2026 | tipranks.comTandem Diabetes Care Earnings Call Highlights GrowthAugust 8, 2026 | tipranks.comSee More Headlines TNDM Stock Analysis - Frequently Asked Questions How have TNDM shares performed this year? Tandem Diabetes Care's stock was trading at $21.98 at the beginning of 2026. Since then, TNDM shares have decreased by 22.2% and is now trading at $17.11. How were Tandem Diabetes Care's earnings last quarter? Tandem Diabetes Care, Inc. (NASDAQ:TNDM) posted its earnings results on Thursday, August, 6th. The medical device company reported ($0.31) earnings per share for the quarter, beating analysts' consensus estimates of ($0.32) by $0.01. The firm's quarterly revenue was up 5.8% compared to the same quarter last year. Read the conference call transcript. When did Tandem Diabetes Care's stock split? Tandem Diabetes Care shares reverse split on the morning of Tuesday, October 10th 2017.The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did Tandem Diabetes Care IPO? Tandem Diabetes Care (TNDM) raised $112 million in an IPO on Thursday, November 14th 2013. The company issued 8,000,000 shares at a price of $13.00-$15.00 per share. Who are Tandem Diabetes Care's major shareholders? Tandem Diabetes Care's top institutional investors include First Light Asset Management LLC (4.86%), California State Teachers Retirement System (1.67%), Wellington Management Group LLP (1.25%) and Beaconlight Capital LLC (0.38%). Insiders that own company stock include Kim D Blickenstaff, John F Sheridan, Mark David Novara, Leigh Vosseller, Dick Allen, Jean-Claude Kyrillos, Kathleen Mcgroddy-Goetz and Shannon Marie Hansen. View institutional ownership trends. How do I buy shares of Tandem Diabetes Care? Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tandem Diabetes Care own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tandem Diabetes Care investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), PayPal (PYPL), Alibaba Group (BABA) and Netflix (NFLX). Company Calendar Last Earnings8/06/2026Today9/14/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 TNDM's financial health is in the Green zone, according to TradeSmith. TNDM has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TNDM CIK1438133 Webwww.tandemdiabetes.com Phone(858) 366-6900FaxN/AEmployees2,500Year Founded2006Price Target and Rating Average Price Target for Tandem Diabetes Care$29.34 High Price Target$55.00 Low Price Target$15.50 Potential Upside/Downside+71.5%Consensus RatingHold Rating Score (0-4)2.48 Research Coverage23 Analysts Profitability EPS (Trailing Twelve Months)($0.93) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$204.71 million Net Margins-6.08% Pretax Margin-5.86% Return on Equity-45.97% Return on Assets-6.23% Debt Debt-to-Equity Ratio4.62 Current Ratio3.18 Quick Ratio2.65 Sales & Book Value Annual Sales$1.01 billion Price / Sales1.17 Cash FlowN/A Price / Cash FlowN/A Book Value$2.29 per share Price / Book7.47Miscellaneous Outstanding Shares69,580,000Free Float68,118,000Market Cap$1.19 billion OptionableOptionable Beta1.55 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:TNDM) was last updated on 9/14/2026 by MarketBeat.com Staff. From Our PartnersA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...Monument Traders Alliance | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredPrint this before your next tradeBill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It'...Profits Run | SponsoredElon Musk to Trigger Next AI Wave on November 11th?Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | Sponsoredyour job is on the listThe CEO of one of the largest AI labs on earth said it plainly: AI could wipe out half of all entry-level whit...Behind the Markets | SponsoredThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
